Dynavax Technologies
DVAX
#5495
Rank
C$1.76 B
Marketcap
C$15.04
Share price
-0.64%
Change (1 day)
-16.37%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : C$0.73 Billion

According to Dynavax Technologies 's latest financial reports the company has C$0.73 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$0.85 B3.79%
2023-12-31$C$0.82 B4.65%
2022-12-31$C$0.78 B178.19%
2021-12-31$C$0.28 B278.69%
2020-12-31$C$74.83 M591.2%
2019-12-31$C$10.82 M-87.4%
2018-12-31$C$85.9 M-65.76%
2017-12-31$C$0.25 B109.29%
2016-12-31$C$0.11 B-53.81%
2015-12-31$C$0.25 B122.56%
2014-12-31$C$0.11 B-41.2%
2013-12-31$C$0.19 B73.68%
2012-12-31$C$0.11 B12.39%
2011-12-31$C$0.10 B95.04%
2010-12-31$C$52.09 M676.44%
2009-12-31$C$6.7 M-65.85%
2008-12-31$C$19.64 M-49.68%
2007-12-31$C$39.03 M-57.6%
2006-12-31$C$92.06 M6.34%
2005-12-31$C$86.57 M20.38%
2004-12-31$C$71.91 M-196.93%
2003-12-31$-C$74.2 Million-16.66%
2002-12-31$-C$89.04 Million62.38%
2001-12-31$-C$54.83 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-C$0.39 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$25.15 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$71.70 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$29.64 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$63.50 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
C$29.25 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$128.61 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$10.02 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$13.28 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA